MedTrace Logo

Integrated Approaches for Identifying Molecular Targets in Liver Disease

NCT03915002 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 155

Last updated 2023-11-07

No results posted yet for this study

Summary

To provide a framework for successful clinical trials testing novel targets for therapy in liver disease.

To identify molecular and cellular drivers of liver disease to provide a molecular classification and study the determinants or key drivers of disease progression.

Consecutive patients admitted with steatohepatitis (alcoholic or non-alcoholic) will be enrolled in this study where liver tissue, blood and stool will be collected to discover and validate factors associated with diagnosis, severity, histological characteristics, development of decompensations, progression of disease and survival.

Conditions

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Jaideep Behari, MD, PhD · Associate Professor

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-13
Primary Completion
2023-04-12
Completion
2023-04-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03915002 on ClinicalTrials.gov